Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, April 12, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, April 11, 2024
[ 12:00 AM ] - United States, WOPRAI
Justin Zelin Initiated (carm) at Strong Buy and Held Target at $6 on, Apr 11th, 2024
Justin Zelin of BTIG, Initiated "Carisma Therapeutics, Inc." (CARM) at Strong Buy and Held Target at $6 on, Apr 11th, 2024.
Justin has made no other calls on CARM in the last 4 months.
There is 1 other peer that has a rating on CARM. Out of the 1 peers that are also analyzing CARM, 0 agree with Justin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Justin
- Mitchell Kapoor of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $9 on, Tuesday, April 2nd, 2024
